The Galaxy System brings advanced imaging, precision targeting and adaptive workflow features into one intelligent platform. True innovation isn’t just about what’s next, it’s about what’s already here.
Match 2 Study: A recent multi-center study conducted with 31 patients evaluated for real-time lesion localization showed 96.7% strict diagnostic yield1
High Diagnostic Accuracy
A prospective and retrospective evaluation of a consecutive patient cohort of 100 patients at the Cleveland Clinic showed 95% diagnostic accuracy2
Favorable Cost-Benefit Ratio
OR cost-benefit ratio and 1.4 EndoSuite cost-benefit ratio were achieved in a recent study of 70 consecutive cases at a Community Hospital3
"The Galaxy System is the robotic game changer we’ve been waiting for.”
1. Mahajan AK, Duong DK, Cortes J, Bhadra K. The match 2 study: Robotic assisted bronchoscopy with integrated imaging with assessment of digital tomosynthesis (DT) and augmented fluoroscopy (AF): Three-Dimensional accuracy as confirmed by cone beam computed tomography (CBCT). Respir Med. 2026 Jan 29;253:108693. doi: 10.1016/j.rmed.2026.108693. Epub ahead of print. PMID: 41620189.
2. Cicenia J, Senyei G, Sethi S, Gillespie C, Di Felice C. (2024, August). INITIAL EXPERIENCE OF A NOVEL ROBOTIC BRONCHOSCOPY SYSTEM WITH INTEGRATED TOOL IN LESION IMAGING [Abstract]. In Journal of Bronchoscopy & Interventional Pulmonology, 2024 conference supplement (Vol. 31, Suppl. 2). Lippincott Williams & Wilkins.
3. Mathew R. Beyond the Scope: Cost-Benefit and Diagnostic Factors in Community-Based Robotic Bronchoscopy. Presented at: CHEST 2025 Conference; October 2025; Chicago, IL, USA
